IgA Testing Now Available
Since we launched our new food and inhalant IgA panels in May, the new panel is very well received.
The Advantage of IgA Testing
US BioTek’s in-house studies have shown that 90-95% of blood samples negative for specific-IgE; 70-85% of these test positive for specific-IgG. Blood samples negative for both specific-IgE and IgG; 30-40% test positive for specific-IgA.
IgA may be ordered independently, or with any IgG panel or any combined IgG/IgE panels, with a simple blood draw or finger stick.
...Read More
Urinary Metabolic Profile & Environmental Pollutants Biomonitor
The latest National-Scale Air Toxics Assessment (NATA) data was released this month, June 2009, from the Environmental Protection Agency, EPA. NATA is a comprehensive nationwide evaluation of air toxins and their cancer risk estimates from chronic inhalation exposure. Cancer risk is based on chronic exposure of toxins at specific concentrations over a lifetime. The latest NATA data based on air toxin emissions information from the year 2002, estimates that on average, about 1 in every 27,000 people in the U.S. have an increased likelihood of contracting cancer from breathing outdoor air toxins at 2002 emission levels over the course of their lifetime
Pollutants from automobile emissions are estimated to account for about 30% of the cancer risk. The majority of this risk is from benzene.
A complete summary of the 2002 assessment is provided on the U.S. EPA website at: http://www.epa.gov/ttn/atw/nata2002/.
...Read More
News Release from FDA July 2009
The FDA’s advisory committee has recently voted to lower the maximum dose of non-prescription acetaminophen in efforts to protect the consumer from potential liver damage from unintentional over use of the drug.
...Read More
